1. 王芳菲,吕少诚,曹迪,任章勇,李立新,贺强*.门静脉积气的病例特点及文献回顾:附6例报告.中华普通外科学文献电子版.2022.16(1).10-13.核心期刊 |
2. Bing Pan, Shao-Cheng Lyu, Qiang He*.Case Report: Spontaneous Rupture of Hepatic Hemangioma.Frontiers in Medicine.2022.9.918748.SCI |
3. Bing Pan#, Fang-Fei Wang#, Qiang He*.Case report: Nocardia farcinica pneumonia in early-stage post liver transplantation.Frontiers in Medicine.2022.9.996045.SCI |
4. 王芳菲,吕少诚,曹迪,任章勇,赵昕,李立新,贺强*.CA19-9/GGT与胰头癌术后远期生存的相关性分析.中华普通外科杂志.2022.37(1).58-59.核心期刊 |
5. 徐俊明,曹爽,张欣雪,刘喆,马军,寇建涛,贺强*.胰腺癌腹腔淋巴结转移相关危险因素分析.北京医学.2022.44(4).418-422.核心期刊 |
6. 潘冰,贺强*.Polo样激酶1的功能及其在肿瘤治疗中的研究进展.国际外科学杂志.2022.49(9).644-648.核心期刊 |
7. 吕少诚,贺强*,郎韧,樊华,李立新,李先亮,寇建涛,刘煜.同种异体静脉在交界可切除胰腺癌中应用的效果及管腔狭窄危险因素分析.中华肝胆外科杂志.2022.28(8).576-581.核心期刊 |
8. 贺强*,任章勇.以门静脉系统重建为标准的交界可切除胰腺癌综合诊疗体系的探讨.中华肝胆外科杂志.2022.28(8).561-566.核心期刊 |
9. 吕少诚,贺强*,郎韧,樊华,李立新,李先亮,寇建涛,刘煜.同种异体静脉置换在腹部外科临床中的应用.中华普通外科杂志.2022.37(1).1-5.核心期刊 |
10. Shaocheng Lyu, Jing Wang, Zhangyong Ren, Di Cao,Qiang He*.Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria_ A Single Center Experience.Current Medical Science.2022.42(3).548-554.SCI |
11. Junming Xu#, Shaocheng Lyu#, Yang Zhao#, Xinxue Zhang, Zhe Liu, Xin Zhao*, Qiang He*.Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.TECHNOLOGY IN CANCER RESEARCH & TREATMENT.2022.21.1-9.SCI |
12. Xinxue Zhang#, Zhangyong Ren#, Junming Xu, Qing Chen, Jun Ma, Zhe Liu, Jiantao Kou, Xin Zhao*, Ren Lang, Qiang He*.MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer.Journal of Oncology.2022.2022.5514715.SCI |
13. Jin-Can Huang#, Bing Pan#, Han-Xuan Wang, Qing Chen, Qiang He*, Shao-Cheng Lyu*.Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft.Journal of Clinical Medicine.2022.11(24).7380.SCI |
14. Zhangyong Ren#, Songping Cui#, Shaocheng Lyu#, Jing Wang, Lin Zhou, Yanan Jia, Qiang He*, Ren Lang*.Establishment of rat allogenic vein replacement model and pathological characteristics of the replaced vessels.Frontiers in Surgery.2022.2022(9).984959.SCI |
15. Bing Pan, ShaoCheng Lyu, Qiang He*.Portal and mesenteric venous calcification in patient with advanced cirrhosis.MEDICINE.2022.101(40).e30766.SCI |
16. Junming Xu#, Bing Pan#, Fangfei Wang, Qiang He*.Impact of lymph node parameters on prognosis of patients with pancreatic ductal adenocarcinoma after radical resection.Asian Journal of Surgery.2022.45(10).1973-1975.SCI |
17. Cheng Ding, ZhangPing Yu, JiQiao Zhu, XianLiang Li, MengHua Dai*, QiangHe*.Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer.DISEASE MARKERS.2022.2022.9737587.SCI |
18. Fangfei Wang, Shaocheng Lyu, Qiang He*.Pneumatosis of portal vein A report of 5 cases.MEDICINA CLINICA.2022.158(6).296-297.SCI |
19. Fei Pan#, Shuang Cao#, Xian-Liang Li, Ya-nan Jia, Ruo-lin Wang, Qiang He*, Ji-Qiao Zhu* .The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients.Frontiers in Medicine.2022.8.779443.SCI |
20. 潘冰,任章勇,赵昕,李立新,吕少诚,贺强*.淋巴结相关参数对远端胆管癌患者术后远期预后的影响.国际外科学杂志.2022.49(12).819-825.核心期刊 |
21. 王华光#,孙熙木#,赵昕,吕少诚,刘丽宏*,贺强*.肝移植术后耶氏肺孢子菌肺炎的预防和治疗.医学综述.2022.28(12).2426-2431.核心期刊 |
22. 赵阳,周林,贺强*.免疫细胞互噬作用在移植免疫中的研究进展.器官移植.2021.12(1).109-114.核心期刊 |
23. 任章勇,吕少诚,贺强*.抗体类免疫诱导剂在实体器官移植中的应用现状.国际外科学杂志.2021.48(1).45-50.核心期刊 |
24. Zhang XX, Zhu JQ, Zhang H, Kou JT, Ma J, He Q*.Resection of a retrohepatic leiomyosarcoma of the inferior vena cava combined with caudate lobectomy and reconstruction with an allogenic vein.Hepatobiliary Pancreat Dis Int.2021.20(1).80-82.SCI |
25. 王芳菲,吕少诚,曹迪,任章勇,赵昕,李立新,贺强*.术前CA199/GGT比值与远端胆管癌术后远期生存的相关性分析.中华肝胆外科杂志.2021.27(10).6-10.核心期刊 |
26. 徐俊明,张欣雪,曹爽,刘喆,马军,寇建涛,贺强*.胰头癌患者术后预后评价及相关危险因素分析.中华普通外科学文献电子版.2021.15(5).9-13.核心期刊 |
27. 贺强*,周林.构建以雷帕霉素为主预防肝癌肝移植术后肿瘤复发的综合防治体系.肝癌电子杂志.2021.8(3).1-7.核心期刊 |
28. 王芳菲,朱继巧,吕少诚,赵昕,李立新,贺强*.结肠下区肠系膜上动脉优先入路在可切除胰头癌外科治疗中的应用.中华胰腺病杂志.2021.21(5).321-325.核心期刊 |
29. Xian-Liang Li#, Zi-Xi Liu#, Zhen-Jia Liu#, Han Li , Benjamin Wilde, Oliver Witzke , Man Qi , Wen-Li Xu , Qiang He* , Ji-Qiao Zhu*.Pneumocystis pneumonia in liver transplant recipients.American Journal of Translational Research.2021.13(12).13981-13992.SCI |
30. 徐俊明,赵昕,贺强*.环状RNA在胰腺癌中的研究进展.中华肝胆外科杂志.2021.27(10).73-77.核心期刊 |
31. 吕少诚,曹迪,任章勇,赵昕,贺强*.CBL联合Mimics软件在胰腺癌规范化培训中的应用.继续医学教育.2021.35(11).26-28.核心期刊 |
32. 吕少诚,王芳菲,任章勇,曹迪,郎韧,贺强*.不同血管重建方式对伴有门静脉系统侵犯胰腺癌术后远期生存的影响.中国医师杂志.2021.23(9).1401-1403.核心期刊 |
33. 任章勇,吕少诚,曹迪,王芳菲,贺强*.远端胆管腺鳞癌8例诊治分析.中华普通外科杂志.2021.36(10).789-790.核心期刊 |
34. 任章勇,吕少诚,王芳菲,李立新,赵昕,贺强*.B10细胞在大鼠胆肠吻合模型中吻合口组织浸润情况的初步研究.国际外科学杂志.2021.48(7).439-444.核心期刊 |
35. 王芳菲,吕少诚,贺强*.肝移植术后早期肺部鼻疽奴卡菌感染一例.中华移植杂志电子版.2021.14(6).394-396.核心期刊 |
36. 李瀚,吕少诚,贾亚男,朱继巧,许文犁,寇建涛,马军,李先亮,贺强*.淋巴细胞相关指标对可切除远端胆管癌患者术后远期生存的影响.中华肝胆外科杂志.2021.27(5).380-382.核心期刊 |
37. 张欣雪,曹迪,吕少诚,赵昕,李立新,贺强*.脂肪肝供体对良性肝病肝移植预后的影响.国际外科学杂志.2021.48(4).238-242.核心期刊 |
38. 吕少诚,任章勇,李立新,贺强 *.新辅助化疗后门静脉系统全置换治疗局部进展期胰腺癌1例报告.中华肝胆外科杂志.2021.27(3).220-222.核心期刊 |
39. 王芳菲,吕少诚,贺强*.门静脉积气病因及机制的研究进展.中华肝胆外科杂志.2021.27(9).717-720.核心期刊 |
40. 徐俊明,周林,贺强*.树突状细胞在器官移植免疫耐受中的研究进展.器官移植.2021.11(5).629-634.核心期刊 |
41. 张欣雪,吕少诚,李先亮,贺强*.纤维蛋白原样蛋白 2 在实体器官移植免疫耐受中作用的研究进展.解放军医学院学报.2021.41(5).532-535.核心期刊 |
42. 周林,李瀚,赵阳,汪京,贾亚男,张欣雪,李先亮,郎韧,贺强*.CD4+CD45RClowTreg在大鼠肝移植免疫耐受中的调节作用研究.器官移植.2021.12(5).579-587.核心期刊 |
43. 吕少诚,贺强*,郎韧,李立新,赵昕,任章勇,曹迪.医源性胆管损伤的外科治疗策略及疗效.中华肝脏外科手术学电子杂志.2021.10(2).181-185.核心期刊 |
44. Han Li #, Lin Zhou# , Ya-Nan Jia , Ruo-Ling Wang, Ji-Qiao Zhu , Xin-Xue Zhang , Wen-Li Xu , Shao-Yan Liu , Qiang He*, Xian-Liang Li*.Plasmacytoid dendritic cells mediate the tolerogenic effect of CD8+regulatory T cells in a rat tolerant liver transplantation model.TRANSPLANT IMMUNOLOGY.2021.70.101508.SCI |
45. Shao-Cheng Lyu#, Fang-Fei Wang#, Di Cao, Qiang He*.Correlation analysis of CA19-9/Glutamyltransferase ratio and long-term survival for patients with distal cholangiocarcinoma under different bilirubin levels.Asian Journal of Surgery.2021.44(11).1421-1422.SCI |
46. 刘荣军,武峤,张兴茂,樊华,贺强*.新微血管侵犯病理分级标准对判断肝癌肝移植术后预后的价值.中国普外基础与临床杂志.2021.28(1).53-57.核心期刊 |
47. Wen-Li Xu # , Ruo-Lin Wang # , Zhe Liu , Qiao Wu , Xian-Liang Li , Qiang He *, Ji-Qiao Zhu *.Granzyme B-Producing B Cells Function as a Feedback Loop for T Helper Cells in Liver Transplant Recipients with Acute Rejection.INFLAMMATION.2021.44(6).2270-2278.SCI |
48. Lin Zhou#, Jing Wang#, Shao-Cheng Lyu#, Li-Chao Pan, Xian-Jie Shi, Guo-Sheng Du, Qiang He*.PD-L1+NEUT, Foxp3+Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma.TECHNOLOGY IN CANCER RESEARCH & TREATMENT.2021.20.1-12.SCI |
49. Shao-Cheng Lyu#, Fang-Fei Wang #, Qiang He*.Cola-caused inflated liver.Clinics and Research in Hepatology and Gastroenterology.2021.45(3).101682.SCI |
50. Shao-Cheng Lyu #, Jing Wang #, Wen-Li Xu , Han-Xuan Wang , Fei Pan , Tao Jiang , Qiang He *, Ren Lang* .Therapeutic Effect of Combining Anisodamine With Neostigmine on Local Scar Formation Following Roux-en-Y Choledochojejunostomy in a Novel Rat Model.Frontiers in Pharmacology.2021.12.700050.SCI |
51. Jing Wang# , Shao-Cheng Lyu# , Ji-Qiao Zhu# , Xian-Liang Li , Ren Lang*, Qiang He*.Extended lymphadenectomy benefits patients with borderline resectable pancreatic head cancer-a single-center retrospective study.Gland Surgery.2021.10(10).2910-2924.SCI |
52. Lin Zhou#, Jing Wang#, Xin-Xue Zhang, Shao-Cheng Lyu, Li-Chao Pan, Guo-Sheng Du, Ren Lang*, Qiang He*.Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World Study.Frontiers in Oncology.2021.11.682928.SCI |
53. Han Li#, Xian-Liang Li#, Shuang Cao, Ya-Nan Jia, Ruo-Lin Wang, Wen-Li Xu , Ren Lang , Qiang He* , Ji-Qiao Zhu*.Decreased granzyme B+CD19+B cells are associated with tumor progression following liver transplantation.American Journal of Cancer Research.2021.11(9).4485-4499.SCI |
54. Xing-Mao Zhang, Qiao Wu, Hua Fan , Qiang He*, Ren Lang*.Reconstructing spleno-mesenterico-portal confluence by bifurcated allogeneic vein in local advanced pancreatic cancer-a feasible method to avoid left-sided portal hypertension.Cancer Medicine.2021.10(16).5448-5455.SCI |
55. Xin Zhao#, Xiao-Shi Zhang# , Xin-Xue Zhang , Tao Jiang , Jia-Lei Zhai , Hua-Guang Wang , Meng-Xiu Huang , Ren Lang* , Qiang He*.MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.American Journal of Cancer Research.2021.11(8).3907-3920.SCI |
56. Xin Zhao, Han Li , Shao-Cheng Lyu, Jia-Lei Zhai , Zhiwei Ji, Zhi-Gang Zhang , Xin-Xue Zhang, Zhe Liu , Hua-Guang Wang , Jun-Ming Xu , Hua Fan , Jian-Tao Kou , Li-Xin Li , Ren Lang , Qiang He*.Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.International Journal of Biological Sciences.2021.17(10).2590-2605.SCI |
57. Long Yang# , Jun Ma# , Qiang He*, Xian-Liang Li*.Immutol regulates CD4 + Tregs, CD8 + Tregs and pDCs via IDO signaling pathway to induce immune tolerance in rat heart allograft transplant.TRANSPLANT IMMUNOLOGY.2021.68.101393.SCI |
58. Shao-Cheng Lyu#, Jing Wang#, Lin Zhou #, Ji-Qiao Zhu , Fei Pan , Tao Jiang, Ren Lang* , Qiang He*.Mechanism of scar formation following Roux-en-Y choledochojejunostomy in a novel rat model of obstructive jaundice.Annals of Translational Medicine.2021.9(6).456-468.SCI |
59. Shao-Cheng Lyu#, Fang-Fei Wang#, Zhang-Yong Ren, Qiang He*.Correlation analysis of CA19-9/Glutamyltransferase ratio and long-term survival for patients with pancreatic head cancer under different bilirubin levels.Asian Journal of Surgery.2021.44(5).765-766.SCI |
60. Shao-Cheng Lyu, Fang-Fei Wang, Zhang-Yong Ren, Di Cao , Qiang He*.Long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy combined with portal vein system resection and reconstruction.LANGENBECKS ARCHIVES OF SURGERY.2021.406(6).1917-1924.SCI |
61. Ji-Qiao Zhu # , Jing Wang # , Xian-Liang Li # , Wen-Li Xu , Shao-Cheng Lv , Xin Zhao , Ren Lang* , Qiang He*.A combination of the percentages of IFN-γ+CD4+T cells and granzyme B+CD19+B cells is associated with acute hepatic rejection: a case control study.Journal of Translational Medicine.2021.19(1).187.SCI |
62. Yang Zhao# , Yu Liu#, Lin Zhou , Xin-Xue Zhang , Ping Li , Qiang He* .Clinical experience of liver transplantation in the treatment of peliosis hepatis.Hepatobiliary & Pancreatic Diseases International.2021.4(33).1-3.SCI |
63. Xin-Xue Zhang#, Jun Ma #, Han Li , Lin Zhou , Zhe Liu , Shao-Cheng Lyu , Qiang He*, Xian-Liang Li*.Overexpression of fibrinogen-like protein 2 alleviates acute rejection in rat models of liver transplantation.Annals of Translational Medicine.2021.9(5).408.SCI |
64. Jing Wang#, Shao-Cheng Lyu#, Lin Zhou, Han Wang, Fei Pan , Tao Jiang , Ren Lang , Qiang He*.Prognostic analysis of pancreatic carcinoma with portal system invasion following curative resection.Gland Surgery.2021.10(1).35-49.SCI |
65. Lin Zhou#, Han Li #, Xin-Xue Zhang , Yang Zhao , Jing Wang , Li-Chao Pan , Guo-Sheng Du , Qiang He* , Xian-Liang Li*.Rapamycin treated tol-dendritic cells derived from BM-MSCs reversed graft rejection in a rat liver transplantation model by inducing CD8+CD45RC??Treg.MOLECULAR IMMUNOLOGY.2021.137(2021).11-19.SCI |
66. Xing-Mao Zhang, Hua Fan , Qiao Wu , Xin-Xue Zhang , Ren Lang , Qiang He*.In-hospital mortality of liver transplantation and risk factors: a single-center experience.Annals of Translational Medicine.2021.9(5).369.SCI |
67. 吕少诚,郎韧,贺强*.肝硬化肝移植手术时机的选择与研究进展.解放军医学院学报.2020.41(08).821-825.核心期刊 |
68. 吕少诚,张志华,李立新,任章勇,曹迪,郎韧,贺强*.远端胆管癌手术预后评价及相关危险因素分析.国际外科学杂志.2020.47(06).369-373.核心期刊 |
69. 王芳菲,吕少诚,贺强*.肝移植术后免疫耐受机制及诱导方法的研究现状.国际外科学杂志.2020.47(6).391-396.核心期刊 |
70. 曹迪,吕少诚,贺强*.FOLFIRINOX方案在不可切除胰腺癌转化治疗中的应用.国际外科学杂志.2020.47(5).346-350.核心期刊 |
71. Zhang XM, Tong Y, Li Q, He Q*.Diffused hepatic angiosarcoma with Kasabach-Merritt syndrome-case report and literature review.BMC Gastroenterol.2020.20(1).80.SCI |
72. 任章勇,吕少诚,贺强*.同种异体血管在肝胆胰手术中的应用现状.解放军医学院学报.2020.41(07).724-727.核心期刊 |
73. Wu Q, Fan H, Lang R, Li X, Zhang X, Lv S, He Q*.Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling.Biomed Res Int.2020.Jun 22.3740418.SCI |
74. Li P, Liu Y, He Q*.Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.Drug Des Devel Ther.2020.Apr 29;14.1609-1620.SCI |
75. 王芳菲, 吕少诚, 贺强*.门静脉积气在成人急腹症中的诊疗进展.国际外科学杂志.2020.47(10).706-710.核心期刊 |
76. 吕少诚,赵昕,李立新,任章勇,曹迪,郎韧,贺强*.远端胆管癌腹腔淋巴结转移的危险因素分析.中华普通外科杂志.2020.35(11).833-837.核心期刊 |
77. 吕少诚,贺强*.肝内胆管细胞癌外科手术治疗的现状与进展.国际外科学杂志.2020.47(2).107-112.核心期刊 |
78. 寇建涛,李先亮,朱继巧,刘子希,白纯,杨龙,李瀚,贾亚男,马军,贺强*.自创免疫状态量化评分标准评估肝移植受者术后免疫状态的可行性分析.中华器官移植杂志.2020.41(06).362-366.核心期刊 |
79. Zhao X, Cao D, Ren Z, Liu Z, Lv S, Zhu J, Li L, Lang R, He Q*.Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.Biosci Rep.2020.40(7).BSR20200214.SCI |
80. Wu Q, Fan H, Lang R, Li X, Zhang X, Lv S, He Q*.Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients.Biomed Res Int.2020.Jun 19.8435420.SCI |
81. Zhao X, Liu Z, Ren Z, Wang H, Wang Z, Zhai J, Cao D, Lyu S, Li L, Lang R, He Q*.Triptolide inhibits pancreatic cancer cell proliferation and migration via T down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F.Eur J Pharmacol.2020.Aug 5;880.173225.SCI |
82. Zhao X, Zhang X, Zhang Z, Liu Z, Zhu J, Lyu S, Li L, Lang R, He Q*.Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma. .Aging (Albany NY).2020.12(22).23251-23274. .SCI |
83. Lyu S, Li L, Zhao X, Ren Z, Cao D, He Q.*.Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy.World J Surg Oncol.2020.18(1).262.SCI |
84. Kou JT, Ma J, Zhu JQ, Xu WL, Liu Z, Zhang XX, Xu JM, Li H, Li XL, He Q*.LncRNA NEAT1 regulates proliferation, apoptosis and invasion of liver cancer.Rev Med Pharmacol Sci.2020.24(8).4152-4160.SCI |
85. 曹迪,吕少诚,贺强*.胆肠吻合术后吻合口瘢痕形成的机制及治疗现状.国际外科学杂志.2020.47(06).402-406.核心期刊 |
86. 吕少诚,赵昕,李立新,任章勇,曹迪,郎韧,贺强*.胰腺癌侵犯门静脉患者的手术预后评价及相关危险因素分析.中华肝胆外科杂志.2020.26(09).656-660.核心期刊 |
87. 寇建涛,刘喆,朱继巧,马军,许文犁,李瀚,贾亚男,李先亮,贺强*.肝移植治疗危重症肝病的临床疗效研究[J]..器官移植.2020.11(04).482-486.核心期刊 |
88. 曹迪,李先亮,张荟,贺强*.影响肝门部胆管癌术后远期预后的因素.首都医科大学学报.2020.41(03).439-443.核心期刊 |
89. 吕少诚,贺强*,郎韧,李立新,赵昕,任章勇,曹迪.外科手术在伴有门静脉系统侵犯的胰腺癌治疗中的临床价值.中华胰腺病杂志.2020.20(04).254-258.核心期刊 |
90. 刘焕业,寇建涛,马军,朱继巧,杨龙,刘子希,李先亮,贺强*.肝移植治疗肝昏迷的围手术期管理经验探讨.器官移植.2019.10(3).323-327.核心期刊 |
91. 潘冰,吕少诚,赵昕,张志华,李平,李立新,郎韧,贺强*.肝门部胆管癌的外科治疗及预后分析.国际外科学杂志.2019.46(2).84-88.核心期刊 |
92. 张荟,吕少诚,潘冰,张兴茂,赵昕,郎韧,樊华,贺强*.非穿透性血管及管状组织闭合系统在联合静脉切除的胰头癌根治术中的应用.中华普通外科杂志.2019.2019(12).1031-1034.核心期刊 |
93. 曹迪,吕少诚,贺强*.肝移植在不可切除结直肠癌肝转移中的应用综述.解放军医学院学报.2019.40(09).897-899.核心期刊 |
94. Shaocheng Lv, Qiang He*.Huge littoral cell angioma of the spleen: a case report.JOURNAL OF NIPPON MEDICAL SCHOOL.2019.86(3).179-182.SCI |
95. 武峤,郎韧,樊华,李先亮,李立新,潘飞,吕少诚,许文犁,范顺利,贺强*.联合门静脉系统血管切除异体血管置换的全胰十二指肠切除术治疗合并血管侵犯胰腺癌的临床疗效.中华消化外科杂志.2019.18(7).683-688.核心期刊 |
96. 潘冰,吕少诚,赵昕,张志华,李平,李立新,郎韧,贺强*.冰冻病理诊断在肝门部胆管癌根治术中的应用.中华普通外科杂志.2019.34(8).656-658.核心期刊 |
97. Jiqiao Zhu, Xianliang Li, Han Li, Zixi Liu, Jun Ma, Jiantao Kou, Qiang He*.Enhanced recovery after surgery pathways benefit patients with soft pancreatic texture following pancreaticoduodenectomy.AMERICAN JOURNAL OF SURGERY.2019.8(5).9610-9615.SCI |
98. 吕少诚,潘冰,李立新,郎韧,李先亮,樊华,赵昕,贺强*.不同肝癌肝移植标准受者预后分析.中华移植杂志(电子版).2019.13(3).206-209.核心期刊 |
99. Zi-Xi Liu , Ji-Qiao Zhu , Jun Ma, Jian-Tao Kou, Xian-Liang Li, Qiang He*.Deceased donor liver transplantation for Budd-Chiari syndrome: Long-segmental thrombosis of the inferior vena cava with extensive collateral circulation.Hepatobiliary & Pancreatic Diseases International.2019.12.783-786.SCI |
100. 刘子希,李先亮,贺强*,朱继巧.分泌颗粒酶B的调节性B细胞在器官移植术后免疫调节作用的研究进展.器官移植.2019.10(6).724-726.核心期刊 |
101. 吕少诚,潘冰,李立新,张志华,郎韧,樊华,李先亮,贺强*.同种异体肝移植术后肺部感染的病原菌分布及耐药性分析.北京医学.2019.41(2).97-99.核心期刊 |
102. 吕少诚,潘冰,李立新,郎韧,李先亮,樊华,李平,贺强*.原发性肝癌肝移植患者预后评价及相关影响因素分析.中华肝胆外科杂志.2019.25(7).493-496.核心期刊 |
103. 马军,吕少诚,寇建涛,李先亮,朱继巧,贺强*,李鹏飞.同种异体肝移植术后真菌感染的病原菌特点及其相关危险因素分析.中国临床药学杂志.2019.35(7).703-705.核心期刊 |
104. 潘冰,吕少诚,赵昕,张志华,李平,李立新,郎韧,贺强*.肝移植围手术期腹腔与胸腔感染病原学分析.中华移植杂志(电子版).2019.13(1).41-44.核心期刊 |
105. 吕少诚,贺强*.吲哚菁绿分子荧光影像技术在精准肝切除术中的应用现状.国际外科学杂志.2019.46(2).81-84.核心期刊 |
106. 吕少诚,王 苑,潘冰,李立新,樊华,李先亮,郎韧,贺强*.肝移植术后腹腔感染的相关危险因素分析.解放军医学院学报.2019.40(1).16-19.核心期刊 |
107. 潘冰, 吕少诚, 郎韧,贺强*.Rh(D)血型不合肝移植一例.中华移植杂志(电子版).2018.12(3).126-127.核心期刊 |
108. 潘冰,吕少诚,李立新,赵昕,张志华,李平,郎韧,贺强*.血管闭合系统在肝移植门静脉重建中的应用分析:附137 例报道.器官移植.2018.9(4).255-260.核心期刊 |
109. 吕少诚,周翔,潘冰,李立新,张志华,郎韧,贺强*.脾窦岸细胞血管瘤二例报道并文献回顾.国际外科学杂志.2018.45(10).688-690.核心期刊 |
110. Zhang X, Zhang J, Fan H, Liu Y, He Q*.Risk factors related to metastasis of para-aortic lymph nodes in pancreatic ductal adenocarcinoma: A retrospective observational study.Medicine (Baltimore).2018.97(40).e12370.SCI |
111. Zhu J, Kou J, Dong H, Ma J, Liu H, Bai C, Li X, He Q*.Biliary reconstruction with a pedicled gallbladder flap in patients during pancreaticoduodenectomy.J Surg Res.2018.225(5).76-81.SCI |
112. Zhu J, Li X, Kou J, Ma J, Li L, Fan H, Lang R, He Q*.Proposed Chaoyang vascular classification for superior mesenteric-portal vein invasion, resection, and reconstruction in patients with pancreatic head cancer during pancreaticoduodenectomy – A retrospective cohort study.Int J Surg.2018.53(5).292-297.SCI |
113. 吕少诚,潘冰,贺强*.肝移植术后围手术期顽固性腹水的诊治进展.国际外科学杂志.2018.45(10).703-707.核心期刊 |
114. Xing-Mao Z, Hong-Juan Z, Qing L, Qiang H*.Pancreatic acinar cell carcinoma—case report and literature review.BMC Cancer.2018.18(1).1083.SCI |
115. Zhang Z, Pan B, Lv S, Ji Z, Wu Q, Lang R, He Q*, Zhao X.Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.Cell Physiol Biochem.2018.49(2).678-695.SCI |
116. Liu Y, Wen PH, Zhang XX, Dai Y, He Q*.Breviscapine ameliorates CCl4??induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation.Int J Mol Med.2018.42(2).755-768.SCI |
117. 潘冰,吕少诚,李立新,贺强*.肝血管瘤自发破裂二例并文献复习.中华肝胆外科杂志.2018.24(6).422-423.核心期刊 |
118. 吕少诚,贺强*,郎韧,李立新,樊华,李先亮,张志华,潘冰.异体血管置换技术在合并血管侵犯的胰腺癌根治性手术中的应用.中华外科杂志.2018.56(4).274-278.核心期刊 |